Cargando…
Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
BACKGROUND: Prospective observations on the effectiveness, safety, tolerance, and influence of comorbidity of add-on lacosamide (LCM) therapy are still lacking, especially for domestic generic LCM in China. OBJECTIVE: In this multicenter real-world study, we aimed to evaluate lacosamide (LCM) as the...
Autores principales: | Liu, Wenyu, Li, Wenjing, Wang, Peiyu, Zhang, Hesheng, Zhang, Enhui, Wu, Xintong, Zhou, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117536/ https://www.ncbi.nlm.nih.gov/pubmed/37090978 http://dx.doi.org/10.3389/fneur.2023.1136814 |
Ejemplares similares
-
Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023) -
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014) -
The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023) -
Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Hou, Liyan, et al.
Publicado: (2021) -
Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)